Tobacco consumption during the COVID-19 pandemic and pharmacokinetic interaction involving cytochrome P-450 with psychoactive drugs: an integrative review

Detalhes bibliográficos
Autor(a) principal: Santos, Jaqueline Rocha Borges dos
Data de Publicação: 2022
Outros Autores: Cruz, Larrysa de Morais Alves da, Lopes, Luís Phillipe Nagem, Matheus, Maria Eline
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/32349
Resumo: This integrative review examines tobacco use related to mental disorders in COVID-19 pandemic and potential interactions involving cytochrome P-450 between tobacco and psychotropic drugs. The five steps of the integrative review development process were considered, namely: elaboration of the guiding question, literature search or sampling, evaluation of data, data analysis, interpretation and presentation of results. A literature search was performed in the Medline and Bireme databases, without language restrictions up to May 2021. Forty-seven articles were found with information on COVID-19, tobacco use and psychiatric illness. Articles were also sought that addressed interactions between major classes of psychotropic drugs and tobacco associated with CYP450 isoforms and genetic polymorphism. Thirty-seven articles were found for interaction among tobacco, cytochrome P450 and antidepressants; 7 including polymorphism; 19 articles involving interaction of tobacco, cytochrome P450 and antipsychotics; 4 including polymorphism; 3 articles describing interaction of tobacco, cytochrome P450 and anxiolytics; 1 including polymorphism; 2 articles regarding interaction of tobacco, cytochrome P450 and mood stabilizers; and 1 including polymorphism. These findings reinforce the importance of recognizing the role of tobacco associated with drug use in mental disorders; indicating the need for monitoring to prevent worsening clinical conditions.
id UNIFEI_25cf40a70a4503d233e543a1bd0fced2
oai_identifier_str oai:ojs.pkp.sfu.ca:article/32349
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Tobacco consumption during the COVID-19 pandemic and pharmacokinetic interaction involving cytochrome P-450 with psychoactive drugs: an integrative review Consumo de tabaco durante la pandemia de COVID-19 e interacción farmacocinética del citocromo P-450 con las drogas psicoactivas: una revisión integradoraConsumo de tabaco durante a pandemia de COVID-19 e interação farmacocinética envolvendo citocromo P-450 com fármacos psicoativos: uma revisão integrativaTabacoCOVID-19Fármacos psicotrópicosInterações medicamentosas.TabacoCOVID-19Fármacos psicotrópicosInteracciones farmacológicas.TobaccoCOVID-19Psychotropic drugsDrug interactions.This integrative review examines tobacco use related to mental disorders in COVID-19 pandemic and potential interactions involving cytochrome P-450 between tobacco and psychotropic drugs. The five steps of the integrative review development process were considered, namely: elaboration of the guiding question, literature search or sampling, evaluation of data, data analysis, interpretation and presentation of results. A literature search was performed in the Medline and Bireme databases, without language restrictions up to May 2021. Forty-seven articles were found with information on COVID-19, tobacco use and psychiatric illness. Articles were also sought that addressed interactions between major classes of psychotropic drugs and tobacco associated with CYP450 isoforms and genetic polymorphism. Thirty-seven articles were found for interaction among tobacco, cytochrome P450 and antidepressants; 7 including polymorphism; 19 articles involving interaction of tobacco, cytochrome P450 and antipsychotics; 4 including polymorphism; 3 articles describing interaction of tobacco, cytochrome P450 and anxiolytics; 1 including polymorphism; 2 articles regarding interaction of tobacco, cytochrome P450 and mood stabilizers; and 1 including polymorphism. These findings reinforce the importance of recognizing the role of tobacco associated with drug use in mental disorders; indicating the need for monitoring to prevent worsening clinical conditions.Esta revisión integradora examina el consumo de tabaco relacionado con los trastornos mentales en la pandemia de COVID-19 y las posibles interacciones que implican al citocromo P-450 entre el tabaco y los fármacos psicotrópicos. Se consideraron los cinco pasos del proceso de desarrollo de la revisión integradora, a saber: elaboración de la pregunta guía, búsqueda de literatura o muestreo, evaluación de datos, análisis de los datos, interpretación y presentación de los resultados. Se realizó una búsqueda bibliográfica en las bases de datos Medline y Bireme, sin restricciones de idioma hasta mayo de 2021. Se encontraron 47 artículos con información sobre la COVID-19, el consumo de tabaco y las enfermedades psiquiátricas. También se buscaron artículos que abordaran las interacciones entre las principales clases de fármacos psicotrópicos y el tabaco asociadas a las isoformas del CYP450 y al polimorfismo genético. Se encontraron 37 artículos sobre la interacción entre el tabaco, el citocromo P450 y los antidepresivos; 7 incluían el polimorfismo; 19 artículos sobre la interacción del tabaco, el citocromo P450 y los antipsicóticos; 4 incluían el polimorfismo; 3 artículos describían la interacción del tabaco, el citocromo P450 y los ansiolíticos; 1 incluía el polimorfismo; 2 artículos sobre la interacción del tabaco, el citocromo P450 y los estabilizadores del estado de ánimo; y 1 incluía el polimorfismo. Estos hallazgos refuerzan la importancia de reconocer el papel del tabaco asociado al consumo de fármacos en los trastornos mentales; indicando la necesidad de control para prevenir el empeoramiento de las condiciones clínicas.Esta revisão integrativa investiga o consumo de tabaco relacionado com enfermidades mentais na pandemia de COVID-19 e potenciais interações envolvendo o citocromo P-450, tabaco e os fármacos psicotrópicos. Foram consideradas as cinco etapas do processo de desenvolvimento da revisão integrativa, a saber: elaboração da pergunta orientadora, pesquisa bibliográfica ou amostragem, avaliação dos dados, análise dos dados, interpretação e apresentação dos resultados. Foi realizada uma pesquisa bibliográfica nas bases de dados Medline e Bireme, sem restrições linguísticas até maio de 2021. Foram encontrados quarenta e sete artigos com informações sobre a COVID-19, o uso do tabaco e doenças psiquiátricas. Foram também procurados artigos que abordassem interações entre as principais classes de fármacos psicotrópicos e tabaco associados às isoformas de CYP450 e polimorfismo genético. Foram encontrados 37 artigos para interação entre tabaco, citocromo P450 e antidepressivos; 7 incluindo polimorfismo; 19 artigos envolvendo interação de tabaco, citocromo P450 e antipsicóticos; 4 incluindo polimorfismo; 3 artigos descrevendo interação de tabaco, citocromo P450 e ansiolíticos; 1 incluindo polimorfismo; 2 artigos envolvendo interação de tabaco, citocromo P450 e estabilizadores de humor; e 1 incluindo polimorfismo. Esses achados reforçam a importância de reconhecer o papel do tabaco associado ao uso de fármacos para enfermidades mentais; indicando a necessidade de monitorização para prevenir o agravamento das condições clínicas.Research, Society and Development2022-07-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3234910.33448/rsd-v11i10.32349Research, Society and Development; Vol. 11 No. 10; e222111032349Research, Society and Development; Vol. 11 Núm. 10; e222111032349Research, Society and Development; v. 11 n. 10; e2221110323492525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/32349/27711Copyright (c) 2022 Jaqueline Rocha Borges dos Santos; Larrysa de Morais Alves da Cruz; Luís Phillipe Nagem Lopes; Maria Eline Matheushttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSantos, Jaqueline Rocha Borges dosCruz, Larrysa de Morais Alves da Lopes, Luís Phillipe Nagem Matheus, Maria Eline2022-08-12T22:23:03Zoai:ojs.pkp.sfu.ca:article/32349Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:48:23.396173Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Tobacco consumption during the COVID-19 pandemic and pharmacokinetic interaction involving cytochrome P-450 with psychoactive drugs: an integrative review
Consumo de tabaco durante la pandemia de COVID-19 e interacción farmacocinética del citocromo P-450 con las drogas psicoactivas: una revisión integradora
Consumo de tabaco durante a pandemia de COVID-19 e interação farmacocinética envolvendo citocromo P-450 com fármacos psicoativos: uma revisão integrativa
title Tobacco consumption during the COVID-19 pandemic and pharmacokinetic interaction involving cytochrome P-450 with psychoactive drugs: an integrative review
spellingShingle Tobacco consumption during the COVID-19 pandemic and pharmacokinetic interaction involving cytochrome P-450 with psychoactive drugs: an integrative review
Santos, Jaqueline Rocha Borges dos
Tabaco
COVID-19
Fármacos psicotrópicos
Interações medicamentosas.
Tabaco
COVID-19
Fármacos psicotrópicos
Interacciones farmacológicas.
Tobacco
COVID-19
Psychotropic drugs
Drug interactions.
title_short Tobacco consumption during the COVID-19 pandemic and pharmacokinetic interaction involving cytochrome P-450 with psychoactive drugs: an integrative review
title_full Tobacco consumption during the COVID-19 pandemic and pharmacokinetic interaction involving cytochrome P-450 with psychoactive drugs: an integrative review
title_fullStr Tobacco consumption during the COVID-19 pandemic and pharmacokinetic interaction involving cytochrome P-450 with psychoactive drugs: an integrative review
title_full_unstemmed Tobacco consumption during the COVID-19 pandemic and pharmacokinetic interaction involving cytochrome P-450 with psychoactive drugs: an integrative review
title_sort Tobacco consumption during the COVID-19 pandemic and pharmacokinetic interaction involving cytochrome P-450 with psychoactive drugs: an integrative review
author Santos, Jaqueline Rocha Borges dos
author_facet Santos, Jaqueline Rocha Borges dos
Cruz, Larrysa de Morais Alves da
Lopes, Luís Phillipe Nagem
Matheus, Maria Eline
author_role author
author2 Cruz, Larrysa de Morais Alves da
Lopes, Luís Phillipe Nagem
Matheus, Maria Eline
author2_role author
author
author
dc.contributor.author.fl_str_mv Santos, Jaqueline Rocha Borges dos
Cruz, Larrysa de Morais Alves da
Lopes, Luís Phillipe Nagem
Matheus, Maria Eline
dc.subject.por.fl_str_mv Tabaco
COVID-19
Fármacos psicotrópicos
Interações medicamentosas.
Tabaco
COVID-19
Fármacos psicotrópicos
Interacciones farmacológicas.
Tobacco
COVID-19
Psychotropic drugs
Drug interactions.
topic Tabaco
COVID-19
Fármacos psicotrópicos
Interações medicamentosas.
Tabaco
COVID-19
Fármacos psicotrópicos
Interacciones farmacológicas.
Tobacco
COVID-19
Psychotropic drugs
Drug interactions.
description This integrative review examines tobacco use related to mental disorders in COVID-19 pandemic and potential interactions involving cytochrome P-450 between tobacco and psychotropic drugs. The five steps of the integrative review development process were considered, namely: elaboration of the guiding question, literature search or sampling, evaluation of data, data analysis, interpretation and presentation of results. A literature search was performed in the Medline and Bireme databases, without language restrictions up to May 2021. Forty-seven articles were found with information on COVID-19, tobacco use and psychiatric illness. Articles were also sought that addressed interactions between major classes of psychotropic drugs and tobacco associated with CYP450 isoforms and genetic polymorphism. Thirty-seven articles were found for interaction among tobacco, cytochrome P450 and antidepressants; 7 including polymorphism; 19 articles involving interaction of tobacco, cytochrome P450 and antipsychotics; 4 including polymorphism; 3 articles describing interaction of tobacco, cytochrome P450 and anxiolytics; 1 including polymorphism; 2 articles regarding interaction of tobacco, cytochrome P450 and mood stabilizers; and 1 including polymorphism. These findings reinforce the importance of recognizing the role of tobacco associated with drug use in mental disorders; indicating the need for monitoring to prevent worsening clinical conditions.
publishDate 2022
dc.date.none.fl_str_mv 2022-07-28
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/32349
10.33448/rsd-v11i10.32349
url https://rsdjournal.org/index.php/rsd/article/view/32349
identifier_str_mv 10.33448/rsd-v11i10.32349
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/32349/27711
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 10; e222111032349
Research, Society and Development; Vol. 11 Núm. 10; e222111032349
Research, Society and Development; v. 11 n. 10; e222111032349
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052769198145536

Registros relacionados